Animal Models of Diabetes and Metabolic Disease 2014View this Special Issue
Research Article | Open Access
Ocular Inflammation in Uveal Tract in Aged Obese Type 2 Diabetic Rats (Spontaneously Diabetic Torii Fatty Rats)
We report uveitis observed in an obese type 2 diabetes rat model, Spontaneously Diabetic Torii Leprfa (SDT fatty) rats aged over 50 weeks. The eyes of SDT fatty rats (16 animals: 7 males and 9 females with 50 or 60 weeks of age) were examined histopathologically. Infiltration of inflammatory cells in the uveal tract was observed in 13 of 16 animals. One female showed severe inflammation affecting the entire uveal tract including the iris, ciliary body, and choroid with a variety of inflammatory cells (neutrophils, lymphocytes, and macrophages). Those changes clinically mimic the findings of diabetic iridocyclitis in diabetic patients. Uveitis associated with diabetes can occur in diabetic patients but the pathogenesis still remains unknown. Since increased extramedullary hematopoiesis in the spleen and abscess in the genital and lower urinary tracts were observed in some SDT fatty rats, increased susceptibility to infection, prolongation of inflammatory states, and disorders of the immune system were considered to be possible factors of the uveitis in aged SDT fatty rats. There have been few reports on how diabetes has influence on the development of uveitis associated with bacterial infection. The SDT fatty rat can be an animal model to investigate diabetes-associated uveitis.
Uveitis can be defined as inflammation in the uveal tract in the eye. Uveitis is the major cause of severe visual impairment in human and has been estimated to account for 5% to 15% of all cases of total blindness in the United States . Diabetes has long been known to increase the chances of a variety of eye diseases, including retinopathy, cataracts, glaucoma, and uveitis . However, the mechanism of cause of diabetes-associated uveitis still remains unknown.
The Spontaneously Diabetic Torii (SDT) fatty rat, established by introducing the fa allele of the Zucker fatty rat into the SDT rat genome, is a new model of obese type 2 diabetes . The SDT-fa/fa (SDT fatty) rat shows overt obesity, hyperglycemia, and hyperlipidemia at a young age as compared with the other diabetes rat models [4, 5]. With an early incidence of diabetes mellitus, diabetes-associated complications in SDT fatty rats were observed at younger ages compared with those in the SDT rats [4–7]. Spontaneous ocular lesions of the SDT fatty rats up to 40 weeks of age have been reported but not in aged SDT fatty rats over 50 weeks of age [4–6]. We examined the eye of the SDT fatty rat over 50 weeks of age histopathologically in both sexes and report its characteristics.
2. Materials and Methods
Male and female SDT-fa/fa (fatty) rats and age-matched SDT-+/+ (SDT) rats were used from our colonies and age-matched Sprague-Dawley (SD) rats were purchased from CLEA Japan, Inc. (Tokyo, Japan). The rats were housed in a climate-controlled room with a temperature of °C, humidity of %, and a 12 h lighting cycle. A basal diet (CRF-1, Oriental Yeast Co., Ltd., Tokyo, Japan) and water were provided ad libitum. All the experiments received prior approval from the committee for the human care and use of animals of our laboratory, in accordance with the Standards Relating to the Care and Management of Experimental Animals. Necropsy was performed on the SDT fatty rats, SDT rats, and SD rat at 50 and 60 weeks of age. All animals were sacrificed by exsanguinations under light ether anesthesia. The eyes were sampled and fixed in formalin-glutaraldehyde mix fixative, then embedded in paraffin, sectioned, stained with hematoxylin and eosin (HE), and examined histopathologically (SDT fatty rats; 16 (7 males and 9 females), SDT rats; 17 (6 males and 11 females), and SD rat; 19 (9 males and 10 females)).
3. Results and Discussion
At necropsy, severe opacity of the lens was observed in all of the SDT fatty rats in both sexes (data not shown). A large-sized spleen and abscess surrounded in the genital and lower urinary tracts were also observed in SDT fatty rats in both sexes. Some SDT fatty rats also showed swelling and thickening of the foot pad, the so-called “bumble foot,” possibly due to the increase in body weight and chronic stimulus from the wire-bottomed cages on the foot pad.
Histologically uveitis, including infiltration of inflammatory cells in the uveal tract in the eye, was observed in 13 of 16 SDT fatty rats of both sexes (Table 1). The inflammatory cells consisted of neutrophils, macrophages, and lymphocytes. The finding was observed mainly in the choroid, but one female showed severe inflammation throughout the iris and ciliary body (Figures 1, 2, 3, 4, and 5). The changes clinically mimic the findings in diabetic iridocyclitis in diabetic patients. Advanced cases with these findings result in posterior synechia and following this are iris bombe and acute glaucoma. In the SDT rats, very slight inflammatory cell infiltration was also observed in the iris and ciliary body but no findings were observed in the choroid. There were increases in the incidence and degree of thickened and disarranged retinal layers (retinal fold) and degenerative lens fiber (cataract) in the SDT fatty rats, compared with those in the SDT rats. The enlarged spleen in the SDT fatty rats was histologically characterized by severely increased extramedullary hematopoiesis (EMH). Myeloid and granulocyte components were predominant in the EMH in the spleen of the SDT fatty rats. A lesion in the foot pad showed histologically ulcer and acanthosis of the epidermis with inflammation (ulcerative pododermatitis).
|−: negative, ±: very slight, +: slight, 2+: moderate, and 3+: severe.|
Uveitis is an inflammatory ocular disease of the uveal tract which is composed of the iris, choroid, and ciliary body. Uveitis can be caused by various factors including infectious or noninfectious (autoimmune) processes, often associated with systemic disease . Although retinopathy is a major diabetic complication in the eye, uveitis can also be observed in diabetic patients [8, 9]. Diabetic patients, 1% to 6%, had uveitis in the iris, the most common localization of uveitis in diabetic humans [8–10]. Destruction of the blood retina barrier, increased blood permeability, and increased susceptibility to infection are considered to be involved in diabetes-associated uveitis but the details of pathogenesis still remain unknown [11–13].
Diabetes has been identified as an important risk factor for infection . Hyperglycemia can induce poor wound healing and increased susceptibility to infection . Once infection occurs in diabetic conditions, inflammation tends to last because diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation . Endotoxin induced uveitis (EIU) is known as an experimental animal model of uveitis initiated by injection of lipopolysaccharide (LPS) [17, 18]. Although inflammatory response in this model lasts only for 72 hours, EIU rats with diabetes induced by streptozotocin (STZ) tended to have a prolonged inflammatory response .
EMH is commonly seen in the normal spleen, especially in young rodents as compared to aged rodents [19, 20]. EMH consists mainly of erythroid and myeloid precursors, indicating physiopathological responses secondary to hemorrhagic and inflammatory conditions, respectively. Increased EMH in the spleen in aged SDT fatty rats could have resulted from infections elsewhere in the body because some SDT fatty rats had severe inflammation in the foot pad and in the lower urinary tract, which could have been caused by bacterial infection. Another hematologic analysis on young SDT fatty rats showed that the leukocyte count (WBC) in SDT fatty rats was significantly higher than that in SD rats . Decreased resistance to infection and a dysregulated inflammatory response may be responsible for the systemic condition of the SDT fatty rats.
Type 2 diabetes has been redefined as an inflammatory disease. The state of the immune system can be altered in obesity and type 2 diabetes, with apparent changes occurring in adipose tissue, liver, pancreatic islets, vasculature, and circulating leukocytes . Type 2 diabetes is associated with higher serum levels of inflammatory cytokines (tumor necrosis factor, TNF) [22–24]. This may be due to the production of TNF in adipose tissue , the activity of advanced glycation end products, or enhanced cytokine production caused by the indirect effects of hyperinsulinemia or hyperglycemia [26, 27]. It is reported that TNF mRNA levels in SDT fatty rats tended to be increased as compared with those in SDT rats .
Aldose reductase inhibitors, which are a class of drugs to prevent eye and nerve damage in diabetic patients, are associated with a decrease in ocular inflammatory complications such as uveitis . When metformin was given to the experimental uveitis model rats induced by an endotoxin, which mimicked the inflammatory effects of bacterial infection, endotoxin induced uveitis was inhibited or was prevented in the metformin group . These cases indicate that diabetes might be one of the contributing factors of uveitis because drugs for diabetes not only improved disorders of carbohydrate metabolism but also decreased ocular inflammation.
Hyperglycemia and dyslipidemia arise at a younger age in the SDT fatty rats compared with other diabetic rat models. Severe and prolonged metabolic disorders in the SDT fatty rats may result in uveitis possibly due to bacterial infection and dysregulated immune system. There are not many reports investigating the association between infection and uveitis by using diabetic animal models, possibly because the mechanism of uveitis is considered to be complicated and multifactorial. The SDT fatty rat is a possibly useful model for investigating the mechanisms of uveitis associated with obesity and diabetes mellitus, especially related to bacterial infection. Whether the SDT fatty rats have stronger susceptibility to infection followed by systemic inflammation leading to uveitis compared to other diabetic models still remains unknown. Further investigation to elucidate potential relationship between metabolic disorder and uveitis in the SDT fatty rats is required.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
T. Ohta and T. Sasase helped in the design of study. Y. Kemmochi, K. Toyoda, T. Ohta, and T. Sasase helped in the data collection and conduct of the study. Y. Kemmochi, K. Miyajima, T. Ohta, K. Toyoda, Y. Yasui, K. Kakimoto, T. Shoda, and A. Kakehashi helped in the analysis of the study. Y. Kemmochi, K. Miyajima, T. Ohta, T. Sasase, K. Kakimoto, T. Shoda, and A. Kakehashi helped in writing the paper.
- R. W. Read, “Uveitis: Advances in understanding of pathogenesis and treatment,” Current Rheumatology Reports, vol. 8, no. 4, pp. 260–266, 2006.
- P. Lin, E. B. Suhler, and J. T. Rosenbaum, “The future of uveitis treatment,” Ophthalmology, vol. 121, no. 1, pp. 365–376, 2014.
- T. Masuyama, Y. Katsuda, and M. Shinohara, “A novel model of obesity-related diabetes: Introgression of the Leprfa allele of the Zucker fatty rat into nonobese Spontaneously Diabetic Torii (SDT) rats,” Experimental Animals, vol. 54, no. 1, pp. 13–20, 2005.
- K. Matsui, T. Ohta, T. Oda et al., “Diabetes-associated complications in Spontaneously Diabetic Torii fatty rats,” Experimental Animals, vol. 57, no. 2, pp. 111–121, 2008.
- Y. Ishii, T. Ohta, T. Sasase et al., “Pathophysiological analysis of female spontaneously diabetic torii fatty rats,” Experimental Animals, vol. 59, no. 1, pp. 73–84, 2010.
- Y. Kemmochi, K. Fukui, M. Maki et al., “Metabolic disorders and diabetic complications in spontaneously diabetic Torii Leprfa rat: a new obese type 2 diabetic model,” Journal of Diabetes Research, vol. 2013, Article ID 948257, 9 pages, 2013.
- Y. Katsuda, T. Ohta, K. Miyajima et al., “Diabetic complications in obese type 2 diabetic rat models,” Experimental Animals, vol. 63, no. 2, pp. 121–132, 2014.
- A. Rothova, H. J. Buitenhuis, C. Meenken et al., “Uveitis and systemic disease,” The British Journal of Ophthalmology, vol. 76, no. 3, pp. 137–141, 1992.
- A. Rothova, C. Meenken, R. P. J. Michels, and A. Kijlstra, “Uveitis and diabetes mellitus,” The American Journal of Ophthalmology, vol. 106, no. 1, pp. 17–20, 1988.
- N. Kitaichi and S. Ohno, “Kosai-en [Iritis],” in Ganka Shinryo Practice (Pract ophthal), M. Wakura, Ed., pp. 162–164, Bunkodo, Tokyo, Japan, 7th edition, 2006.
- J. Greenwood, “The blood-retinal barrier in experimental autoimmune uveoretinitis (EAU): a review,” Current Eye Research, vol. 11, pp. 25–32, 1992.
- K. Yamashiro, S. Ishida, T. Usui, Y. Kaji, and Y. Ogura, “VEGF dependent leukocyte infiltration and blood-retinal barrier breakdown in endotoxin-induced uveitis,” Investigative Ophthalmology & Visual Science, vol. 44, p. U215, 2003.
- U. Pleyer and J. V. Forrester, Eds., Uveitis and Immunological Disorders: Progress III, Springer, New York, NY, USA, 2010.
- G. Naguib, H. Al-Mashat, T. Desta, and D. T. Graves, “Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation,” Journal of Investigative Dermatology, vol. 123, no. 1, pp. 87–92, 2004.
- S. Guo and L. A. DiPietro, “Critical review in oral biology & medicine: factors affecting wound healing,” Journal of Dental Research, vol. 89, no. 3, pp. 219–229, 2010.
- S. Rossi, M. D'Amico, A. Capuano, M. Romano, P. Petronella, and C. di Filippo, “Hyperglycemia in streptozotocin-induced diabetes leads to persistent inflammation and tissue damage following uveitis due to reduced levels of ciliary body heme oxygenase-1,” Mediators of Inflammation, vol. 2006, Article ID 60285, 6 pages, 2006.
- A. Okumura, M. Mochizuki, M. Nishi, and C. P. Herbort, “Endotoxin-induced uveitis (EIU) in the rat: a study of inflammatory and immunological mechanisms,” International Ophthalmology, vol. 14, no. 1, pp. 31–36, 1990.
- R. R. Caspi, “A look at autoimmunity and inflammation in the eye,” Journal of Clinical Investigation, vol. 120, no. 9, pp. 3073–3083, 2010.
- C. H. Kim, “Homeostatic and pathogenic extramedullary hematopoiesis,” Journal of Blood Medicine, vol. 1, pp. 13–19, 2010.
- A. W. Suttie, “Histopathology of the spleen,” Toxicologic Pathology, vol. 34, no. 5, pp. 466–503, 2006.
- M. Y. Donath and S. E. Shoelson, “Type 2 diabetes as an inflammatory disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 98–107, 2011.
- A.-C. Desfaits, O. Serri, and G. Renier, “Normalization of plasma lipid peroxides, adhesion, and tumor necrosis factor-α production in NIDDM patients after gliclazide treatment,” Diabetes Care, vol. 21, no. 4, pp. 487–493, 1998.
- A. Katsuki, Y. Sumida, S. Murashima et al., “Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 3, pp. 859–862, 1998.
- Y. Mishima, A. Kuyama, A. Tada, K. Takahashi, T. Ishioka, and M. Kibata, “Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 52, no. 2, pp. 119–123, 2001.
- G. S. Hotamisligil and B. M. Spiegelman, “Tumor necrosis factor α: a key component of the obesity-diabetes link,” Diabetes, vol. 43, no. 11, pp. 1271–1278, 1994.
- M. Soop, H. Duxbury, A. O. Agwunobi et al., “Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans,” American Journal of Physiology—Endocrinology and Metabolism, vol. 282, no. 6, pp. E1276–E1285, 2002.
- H. Vlassara and M. R. Palace, “Diabetes and advanced glycation endproducts,” Journal of Internal Medicine, vol. 251, no. 2, pp. 87–101, 2002.
- H. Morinaga, T. Ohta, K. Matsui et al., “Effect of food restriction on adipose tissue in spontaneously diabetic Torii fatty rats,” Experimental Diabetes Research, vol. 2009, Article ID 715057, 9 pages, 2009.
- U. C. Yadav, S. K. Srivastava, and K. V. Ramana, “Aldose reductase inhibition prevents endotoxin-induced uveitis in rats,” Investigative Ophthalmology and Visual Science, vol. 48, no. 10, pp. 4634–4642, 2007.
- N. M. Kalariya, M. Shoeb, N. H. Ansari, S. K. Srivastava, and K. V. Ramana, “Antidiabetic drug metformin suppresses endotoxin-induced uveitis in rats,” Investigative Ophthalmology and Visual Science, vol. 53, no. 7, pp. 3431–3440, 2012.
Copyright © 2014 Yusuke Kemmochi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.